Sunflo Pharmaceuticals Private Limited
About Sunflo Pharmaceuticals Private Limited
Data last updated:
Sunflo Pharmaceuticals Private Limited was a private limited company based in Kalyan, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 08 August 2014.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2014PTC257020. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Aasma Abdulmajid Pirjade and Jyoti Suresh Sonawane.
Its last annual general meeting (AGM) was held on 20 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Shop No – 115 D Blossom Chs Ltd D Wing Raheja Complex Nr Patri Pool Kalyan, Maharashtra, India – 421301.
As per the financials filed for FY 2018, the company reported a revenue of ₹6.24 Lakh, a decline of 53% compared to the previous year. For the same year it recorded EBITDA of ₹1,695 (EBITDA margin 0.3%). Revenue has grown at a compounded annual rate (CAGR) of 111% over three years.
Company details
Contact details
Sunflo Pharmaceuticals Private Limited's registered office is in Kalyan, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No – 115 D Blossom Chs Ltd D Wing Raheja Complex Nr Patri Pool Kalyan, Maharashtra, India – 421301
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Sunflo Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sunflo Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sunflo Pharmaceuticals Private Limited, buy the company report.
Financials of Sunflo Pharmaceuticals Private Limited
FY 2018 filings availableSunflo Pharmaceuticals Private Limited reported revenue of ₹6.24 Lakh (down 53% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 53% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 111%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1,695 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.3% | |||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sunflo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sunflo Pharmaceuticals Private Limited
Sunflo Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aasma Abdulmajid Pirjade Also directs: Bio Bridge Consultants LLP | Director | 27 Jul 2016 | 10 Years 3 Months | As last reported |
| Jyoti Suresh Sonawane | Director | 27 Jul 2016 | 10 Years 3 Months | As last reported |
Auditor
Sunflo Pharmaceuticals Private Limited is audited by MANOJ H JAISWAL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANOJ H JAISWAL | FY 2017 | 150561 |
Shareholding
The shareholding of Sunflo Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sunflo Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sunflo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunflo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sunflo Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sunflo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sunflo Pharmaceuticals Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Aasma Abdulmajid Pirjade ceased to be Additional Director on 03 Nov 2017.
Frequently asked questions
Sunflo Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Sunflo Pharmaceuticals was a private limited company based in Kalyan, Maharashtra, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 08 August 2014 and is registered under CIN U74120MH2014PTC257020. The company has been struck off by the Registrar of Companies and is no longer operational.
Sunflo Pharmaceuticals had 2 directors:
- Aasma Abdulmajid Pirjade - Director
- Jyoti Suresh Sonawane - Director
The CIN (Corporate Identification Number) of Sunflo Pharmaceuticals is U74120MH2014PTC257020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sunflo Pharmaceuticals is at Shop No – 115 D Blossom Chs Ltd D Wing Raheja Complex Nr Patri Pool Kalyan, Maharashtra, India – 421301.
Sunflo Pharmaceuticals was incorporated on 08 August 2014. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Sunflo Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 20 September 2018. Year-wise statements from 2015 are in the company report.
No. Sunflo Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Sunflo Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Aasma Abdulmajid Pirjade ceased to be Additional Director on 03 Nov 2017. Jyoti Suresh Sonawane ceased to be Additional Director on 03 Nov 2017. Aasma Abdulmajid Pirjade was appointed as Director on 27 Jul 2016. Sunflo Pharmaceuticals has 6 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
